Home > Boards > US Listed > Biotechs > NantKwest (NK)

It was obvious this was a bad investment

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
wilma6311 Member Profile
 
Followed By 87
Posts 10,391
Boards Moderated 0
Alias Born 07/22/11
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/9/2019 4:43:47 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/4/2019 6:01:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/23/2019 4:10:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:05:50 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/7/2019 4:02:57 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 4:09:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2019 5:47:09 PM
NantKwest Launches First-in-class, First-in-human Phase I Clinical Trial With a Targeted PD-L1 t-haNK Cell Therapy in Patient... Business Wire - 6/24/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2019 4:04:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:48:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:45:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:42:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:40:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:36:37 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/7/2019 4:32:37 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 4:07:44 PM
Cheryl Cohen Appointed to NantKwest’s Board of Directors Business Wire - 6/6/2019 4:10:00 PM
NantKwest Announces Durable Complete Responses in Multiple Advanced-Stage Solid Tumor Cancers Following Off-the-Shelf NK Cell... Business Wire - 6/4/2019 8:00:00 AM
NantKwest Announces Updated Clinical Results for Nanatinostat (VRx-3996), a Novel HDAC Inhibitor Being Developed in Partnersh... Business Wire - 6/4/2019 7:45:00 AM
NantKwest Launches First-in-Human Targeted NK Phase I Clinical Trial of CD19 T-haNK Cell Therapy in Lymphoma Patients Business Wire - 6/3/2019 2:50:00 PM
NantKwest to Present and Provide Update at Upcoming Jefferies 2019 Annual Healthcare Conference Business Wire - 6/3/2019 8:00:00 AM
NantKwest, NantCell & NantOmics to Provide Updated Preclinical & Clinical Data in Four Abstracts at Part of the American Soci... Business Wire - 5/31/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/8/2019 4:10:11 PM
Brink Biologics Announces Research License Agreement with Worcester Polytechnic Institute for Use of NantKwest’s NK-92®... Business Wire - 5/1/2019 8:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/26/2019 4:13:38 PM
wilma6311   Thursday, 05/19/16 06:09:55 PM
Re: None
Post # of 1171 
It was obvious this was a bad investment from the start. Immediately the pps began to plummet and then the first filing that came out saying they had 166mil in debt was a great indicator.

That on top of the numerous lawsuits was a no brainer that this elevator ride was going down fast.

A year ago I said this would be in single digits in a year. It actually happened faster than that.

The new prediction is under a buck by the end of the summer. I would never have stooped so low to buy this in the first place. Its worse than a penny stock.

If anyone says they have an investment philosophy, remind them that a monkey picked a winning portfolio over a fund manager...then fling your poop at them.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist